Detalhe da pesquisa
1.
The association of age at psoriasis onset and HLA-C*06:02 with biologic survival in patients with moderate-to-severe psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR).
Br J Dermatol
; 190(5): 689-700, 2024 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38051972
2.
Effectiveness and survival of methotrexate versus adalimumab in patients with moderate-to-severe psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR).
Br J Dermatol
; 189(3): 271-278, 2023 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37226927
3.
Effectiveness and persistence of acitretin, ciclosporin, fumaric acid esters and methotrexate for patients with moderate-to-severe psoriasis: a cohort study from BADBIR.
Br J Dermatol
; 188(5): 618-627, 2023 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36763783